financetom
Business
financetom
/
Business
/
ServiceNow to Acquire AI Startup Moveworks for $2.85 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ServiceNow to Acquire AI Startup Moveworks for $2.85 Billion
Mar 10, 2025 11:43 AM

02:26 PM EDT, 03/10/2025 (MT Newswires) -- ServiceNow ( NOW ) said Monday it has agreed to acquire artificial intelligence startup Moveworks for $2.85 billion in a cash-and-stock deal as the cloud computing services provider looks to bolster its AI assistant offering.

Moveworks is behind a front-end AI assistant and enterprise search technology that is used by customer service agents. It counts Toyota ( TM ) , Unilever ( UL ) , Palo Alto Networks ( PANW ) , and Instacart (CART) among its customers. The company's new platform has increased to almost 5 million employee users in about 18 months.

ServiceNow ( NOW ) said it's already one of Moveworks' more than 100 technology integrations. The companies have roughly 250 mutual customers, according to ServiceNow ( NOW ).

"Moveworks' talented team and elegant AI-first experience, combined with ServiceNow's ( NOW ) powerful AI-driven workflow automation, will supercharge enterprise-wide AI adoption and deliver game-changing outcomes for employees and their customers," said Amit Zavery, president, chief operating officer, and chief product officer at ServiceNow ( NOW ).

The company's shares were down 7.6% in Monday afternoon trade.

"Becoming part of ServiceNow ( NOW ) presents an incredible opportunity to accelerate our innovation," Moveworks co-founder and Chief Executive Bhavin Shah said.

The deal is expected to close in the second half of this year, subject to regulatory approvals and other conditions. ServiceNow ( NOW ) expects the acquistion to help drive the use of its AI platform to "accelerate enterprise adoption and innovation" across customer relationship management and other key growth areas, according to the statement.

ServiceNow ( NOW ) said that as of the end of 2024, it had almost 1,000 AI customers and had exceeded $200 million in annual contract value for its Pro Plus AI offering.

Price: 783.40, Change: -67.23, Percent Change: -7.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
REUTERS NEXT-US bank executives expect Trump to ease rules, fuel growth
REUTERS NEXT-US bank executives expect Trump to ease rules, fuel growth
Dec 11, 2024
NEW YORK (Reuters) - President-elect Donald Trump is expected to adopt pro-growth policies that ease U.S. banking and credit card regulations, while spurring deals, industry executives said on a panel at the Reuters NEXT conference in New York on Wednesday. I hope the new administration will use this as a point to do a reset, Barclays U.S. consumer Bank CEO Denny Nealon...
Pharming Reports Positive Phase III Data on Leniolisib in Children With Rare Primary Immunodeficiency; Shares Rise
Pharming Reports Positive Phase III Data on Leniolisib in Children With Rare Primary Immunodeficiency; Shares Rise
Dec 11, 2024
11:00 AM EST, 12/11/2024 (MT Newswires) -- Pharming Group ( PHAR ) reported Wednesday positive phase III data for its investigational drug leniolisib in children aged between four and 11 years with activated phosphoinositide 3-kinase delta syndrome, a rare primary immunodeficiency. The biopharmaceutical company said the data was consistent with improvements seen in a previously reported randomized controlled trial in...
Figs Stock Jumps On Takeover Offer From Private-Equity Firm
Figs Stock Jumps On Takeover Offer From Private-Equity Firm
Dec 11, 2024
FIGS Inc ( FIGS ) shares are trading higher Wednesday following reports suggesting the company received a takeover offer from Story3 Capital Partners. What To Know: According to a Wall Street Journal report, private-equity firm Story3 Capital Partners sent a takeover offer to medical-apparel maker Figs, valuing the company at more than $1 billion. The private-equity firm reportedly offered $6...
Enlivex Therapeutics Gets Approval for Phase 1 Trial of Allocetra to Treat Osteoarthritis
Enlivex Therapeutics Gets Approval for Phase 1 Trial of Allocetra to Treat Osteoarthritis
Dec 11, 2024
11:02 AM EST, 12/11/2024 (MT Newswires) -- Enlivex Therapeutics ( ENLV ) said Wednesday it received authorization from the Israeli Ministry of Health to start a phase 1 clinical trial of Allocetra after injection into the temporomandibular joint in osteoarthritis patients. The company intends to evaluate the frequency and severity of adverse events, including serious adverse events, as the primary...
Copyright 2023-2026 - www.financetom.com All Rights Reserved